Literature DB >> 9511783

Obstructive sleep apnea due to endogenous testosterone production in a woman.

D D Dexter1, E J Dovre.   

Abstract

Obstructive sleep apnea (OSA) is a common condition characterized by snoring, recurrent episodes of cessation of breathing (obstructive apneas), disrupted sleep, and excessive daytime somnolence. Associated serious complications are hypertension, increased risk of heart disease, stroke, and increased susceptibility to industrial and motor vehicle accidents. OSA is considerably more common in men than in women. In postmenopausal women, the incidence of OSA increases. These factors suggest that reproductive hormones have a role in the cause of OSA. Treatment with testosterone has been reported to cause OSA in men, and exogenous androgen administration has been reported to cause OSA in one woman. In a review of the English literature, we found no previous reports of OSA that was induced by endogenous testosterone in women. Herein we describe a nonobese 70-year old woman with clinically significant OSA and a benign testosterone-producing ovarian tumor. After successful removal of the tumor, her OSA resolved, and her testosterone level normalized. This unique case supports the theory of male hormonal (testosterone) influence in the OSA syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9511783     DOI: 10.4065/73.3.246

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  10 in total

Review 1.  Gender difference in snoring and how it changes with age: systematic review and meta-regression.

Authors:  Chung-Hong Chan; Billy M Wong; Jin-Ling Tang; Daniel K Ng
Journal:  Sleep Breath       Date:  2011-09-22       Impact factor: 2.816

2.  Neuroendocrine alterations in obese patients with sleep apnea syndrome.

Authors:  Fabio Lanfranco; Giovanna Motta; Marco Alessandro Minetto; Matteo Baldi; Marcella Balbo; Ezio Ghigo; Emanuela Arvat; Mauro Maccario
Journal:  Int J Endocrinol       Date:  2010-02-23       Impact factor: 3.257

3.  On Not Knowing What We Don't Know to Knowing What We Don't Know: Obstructive Sleep Apnea in the Transgender Community.

Authors:  David C Earl; Lee K Brown
Journal:  J Clin Sleep Med       Date:  2019-10-15       Impact factor: 4.062

Review 4.  Interactions between obstructive sleep apnea and the metabolic syndrome.

Authors:  Anna Svatikova; Robert Wolk; Apoor S Gami; Michal Pohanka; Virend K Somers
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

5.  The Effects of Transgender Hormone Therapy on Sleep and Breathing: A Case Series.

Authors:  Brian D Robertson; Brian S Lerner; Jacob F Collen; Patrick R Smith
Journal:  J Clin Sleep Med       Date:  2019-10-15       Impact factor: 4.062

Review 6.  Gender differences in obstructive sleep apnea and treatment implications.

Authors:  Christine M Lin; Terence M Davidson; Sonia Ancoli-Israel
Journal:  Sleep Med Rev       Date:  2008-10-31       Impact factor: 11.609

Review 7.  Pharmacotherapies for obstructive sleep apnoea: where are we now?

Authors:  Ian E Smith; Timothy G Quinnell
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  Obstructive sleep apnoea in the elderly: recognition and management considerations.

Authors:  Timothy G Quinnell; Ian E Smith
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature.

Authors:  Nafiye Helvaci; Erdem Karabulut; Ahmet Ugur Demir; Bulent Okan Yildiz
Journal:  Endocr Connect       Date:  2017-07-24       Impact factor: 3.335

10.  Serum testosterone/cortisol ratio in people with obstructive sleep apnea.

Authors:  Hiwa Mohammadi; Mohammad Rezaei; Amir Sharafkhaneh; Habibolah Khazaie; Mohammad Rasoul Ghadami
Journal:  J Clin Lab Anal       Date:  2019-09-23       Impact factor: 2.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.